Key result
Atrial fibrillation was associated with less favorable changes in mitral valve area compared to sinus rhythm after percutaneous balloon mitral valvuloplasty.
Why the study?
The effects of percutaneous balloon mitral valvuloplasty in patients with mitral stenosis and atrial fibrillation compared to those with sinus rhythm were unclear.
Does percutaneous balloon mitral valvuloplasty result in different outcomes in patients with mitral stenosis and atrial fibrillation compared to those in sinus rhythm?
Meta-Analysis (n=6,351)
Does percutaneous balloon mitral valvuloplasty result in different outcomes in patients with mitral stenosis and atrial fibrillation compared to those in sinus rhythm?
Answers are grounded in this paper and cite their sources.
Percutaneous balloon mitral valvuloplasty is less effective in improving mitral valve area and is associated with worse clinical outcomes in mitral stenosis patients with atrial fibrillation compared to those in sinus rhythm.
OBJECTIVE: The study aimed to systematically review the existing literature and assess the effects of percutaneous balloon mitral valvuloplasty (PBMV) in patients with mitral stenosis and atrial fibrillation (AF) as opposed to sinus rhythm (SR). METHODS: Eligible studies were identified from six electronic databases before June 2021. The primary outcome was mitral valve area (MVA), and secondary outcomes were hemodynamic measurements, in-hospital complications, and long-term outcomes. Relative risks (RRs) or weighted mean differences (WMDs) with 95% confidence intervals (CIs) were used as effect sizes. RESULTS: Fifteen studies were included involving 6351 patients. For the primary outcome, the AF group obtained less favourable changes in MVA (WMD: -0.10, 95%CI: -0.14, -0.06) and a significantly smaller postoperative and long-term MVA (WMD: -0.13, 95%CI: -0.18, -0.08 and WMD: -0.10, 95%CI: -0.17, -0.03, respectively) compared to the SR group. For secondary outcome, the AF group was associated with suboptimal outcomes as following (WMD/RR, [95%CI]): higher LAP (1.37, [0.86, 1.87]), more embolism (2.85, [1.44, 5.63]), lower event-free survival (0.89, [0.80, 1.00]), higher incidences of mitral valve replacement (2.20, [1.40, 3.46]), re-PBMV (2.28, [1.63, 3.19]), and mortality (3.28, [2.42, 4.44]). No significant differences were found in other outcomes. CONCLUSIONS: The currently available evidence suggests that PBMV may be less effective in patients with AF than in those with SR. However, early treatment and appropriate management of AF patients undergoing PBMV may benefit the immediate and long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) conducted a meta-analysis in Mitral stenosis (n=6,351). Atrial fibrillation vs. Sinus rhythm was evaluated on Changes in mitral valve area (MVA) (WMD -0.10, 95% CI -0.14, -0.06). Atrial fibrillation was associated with less favorable changes in mitral valve area compared to sinus rhythm after percutaneous balloon mitral valvuloplasty.
Synapse has enriched 10 related papers. Consider them for comparative context: